Go Freelance Jobs

Eric Lefkofsky: Tempus Labs and Cancer Research

Eric Lefkofsky is a highly influential entrepreneur in Chicago. He has co-founded and founded many startup businesses in and around the city. One of the companies that he co-founded and launched is known as Tempus Labs. The lab has only been open for three years now, and is already known as a top ten health technology startup. Tempus Labs is a highly successful cancer research and biotechnology business. Some of the technologies they have discovered include gene editing, gene therapy, skin cancer diagnosis, sequencing technology for pathogens, glucose monitors, cancer immunotherapy using CAR-T, eye disease artificial intelligence, KardiaBand, and blood pressure watches. Tempus Labs is also in collaboration with almost all Cancer Institutes in the country.

Gene editing and gene therapy were thought to be useless. But, voretigene neparvovec-rzyl was accepted in 2017 for the treatment of blindness from a rare kind of inherited vision loss. Soon, the outcome will be noted whether the therapy was successful or not. Stanford University scientists successfully developed an algorithm to identify benign and malignant lesions. This algorithm should be a sufficient tool for the immense understanding of skin cancer technology.

KardiaBand was designed by AliveCor. It alerts the patient if they have heart rate outliers through an algorithm method. The FreeStyle Libre Flash glucose monitor is used for directly dosing insulin. The Dexcom sensor will monitor an arm or abdomen and send the information to the patient’s smartphone or watch. Also on the list, is a blood pressure smartwatch. It will read the pressure through the radial artery and is now FDA approved.

Next, pathogen sequencing technology uses tools to understand the pathogens genomes for public heath responses as needed. Following this, CAR-T immunotherapy is changing hematologic malignancy treatments. The two drugs approved are Axicabtagene ciloleucel and tisagenlecleucel-T. Last on the list is artificial eye disease technology, it is more easily used for detecting eye diseases.

Eric Lefkofsky graduated with a Juris Doctor from the University of Michigan Law School. He is the author of Accelerated Disruption, and an adjunct professor at the University of Chicago. To learn more go to www.lefkofsky.com.

Learn More: chicago.blueskyinnovation.com/vault/network/lefkofsky-eric/

Transforming Treatment in Urology

Since June 2013, Dr. David Samadi has been the chairman of urology and chief of robotic surgery at Lenox Hospital. It seems robotic surgery has been a keen interest of Dr. David Samadi. Before he joined Lenox Hill, he was working at Mount Sinai Hospital. Here, he was chief of the robotic surgery as well. Dr. Samadi’s specialty is urology or oncologist. He is an expert in prostate cancer.

When treating cancer, one has an option of choosing radiation, chemotherapy or surgery. Dr. Samadi is a leader in the minimally invasive surgery department. So far he has undertaken more than seven thousand robot-assisted surgeries on the prostate.

Apart from prostate, Dr. Samadi also treats kidney and bladder cancer. These are urologic illnesses as well. He uses treatments such as laparoscopic radical prostatectomy. He could also use laparoscopic robotic radical prostatectomy. Whatever approach of treatment he uses depends on the illness and how best to treat it,

Samadi has his roots in Iran. He was born and raised there until he was a teenager. They were forced to leave their home because of political reasons. This issue caused a separation between Samadi, his brother, and their parents. Samadi and his brother pursued their ambitions in America and made their parents proud.

Dr. David Samadi began his education in Belgium and London before his final settlement in America. His first degree was in biochemistry at Stony Broke University. He was lucky to be under scholarship. Dr. Samadi went ahead to get his training in urology at Albert Einstein College of Medicine. Other areas he attained were a fellowship in oncology and another one in robotic radical prostatectomy.

All these accomplishments of education have played a major role in making him the person he is. He is one of the top doctors who are good at minimally invasive surgery. Robotic surgery is a modern method of treatment that has proved to be efficient and effective to patients. Dr. Samadi has done hundreds of these surgeries, and they have been successful. Apart from offering treatment to patients, Dr. David Samadi is keen to make publications on urology topics. He recently talked about the statistics of prostate cancer. Particularly, he mentioned political personalities who were diagnosed but successfully treated after going through surgery. In his article, Dr. Samadi states Mitt Romney, Colin Powel, and John Kerry are all former patients with prostate cancer. They chose surgery, which went well and we all hope for the best in their health. He is keen to remind people of staying healthy. Promoting health is the main reason for making these publications.

Eric Lefkofsky: Creating a Cancer Genomic Database

Creation of a cancer genomic database is a revolutionary idea that Eric Lefkofsky has dedicated significant amount of resources towards its success. The serial investor is driven by the belief that such a database will facilitate deeper understanding cancer as doctors will be able to compare the DNA of their cancer patients. Ultimately, the database will be crucial in developing effective cancer management practices for cancer patients. However, the greatest potential that an extensive cancer genomic database comprising of DNA samples of cancer patients is the development of customized cancer therapies and cures for cancer patients. This will translate to longer lives and high quality of life despite suffering from cancer.

To achieve this goal, Eric Lefkofsky cofounded Tempus together with his longtime business partner Brad Keywell. The technology startup will take advantage of the current advanced technologies to screen cancer patients and store their genomic data after sequencing for further processing and consumption within the oncology community. Towards this end, Tempus has already partnered with various hospitals constructed a 20,000 –square-foot lab. Additionally, the company has hired some of the best research scientists including the renowned geneticist, Kevin White. Tempus has also developed as a gene sequence comparison software to facilitate success of the new initiative.

Education Background and Skillset

Eric Lefkofsky is a multitalented serial investor with strong academic background complemented by a plethora of skills. Between 1987 and 1991, he studied for his undergraduate degree at the University of Maryland. After graduating top of his class, he furthered his education with a Juris Doctor degree at the University of Michigan Law School between 1991 and 1994. The founder of numerous startups in various industries including financial services and investment industries is highly skilled in entrepreneurship.

The Groupon and MediaBank cofounder also has excellent new business development and startup skills, which have been integral in his successful cofounding several startups such as Uptake is a specialist in business development, online marketing and advertising, and venture capital. His successes in the technology industry including the successful launch of Tempus, Inc. are hinged on his strategic vision, technological innovation and computational biology skills.

To know more visit @: http://adrinkwith.com/eric-lefkofsky/

Customized Cancer Care Benefits All

Cancer Treatment Centers of America has merged with NantHealth and Allscripts to launch Clinical Pathways. The integration of the three healthcare centers combine treatment, electronic medical record integration and clinical decision support under one data format. This allows clinicians treating patients access to all aspects of patient care from any one of the clinical centers.

According to Wikipedia, electronic medical records that are updated in real time and accessible by all caregivers gives patients freedom from obtaining scans and blood test results and memorizing drug names as they visit various caregivers during the course of their treatment. It allows doctors accurate and up to date records of each patient with the speed of electronic records. This is much more efficient in the treatment of patients saving time and money.

CTCA are a group of five hospitals that specialize only in the treatment of cancer. Their expert oncologists and support physicians and staff use state of the art equipment to diagnose, treat and monitor all aspects of cancer care. They have hospitals in Philadelphia, Atlanta, Tulsa, Chicago and Phoenix.

Cancer Treatment Centers of America are different than any other cancer care obtained anywhere else. Since they only treat cancer, they are highly trained and experienced in all aspects of its treatment and management. They realize that cancer is different in every patient and every patient is unique. Each patient gets an individualized course of treatment and care designed just for them. Since cancer diagnosis and treatment can be overwhelming, a coordinator is assigned to each patient to help manage appointments, medications and daily details of their care. Care team collaboration makes this center unique and successful in treating cancer patients

The Significance of Eric Lefkofsky in Cancer Treatment Research


Eric Lefkofsky is a prominent entrepreneur and a philanthropist. He is co-founder and CEO of Tempus, a technology company known for creating a platform to fight cancer. He is also the founder of Groupon, co-founder Lightbank, Uptake Technologies, Mediaocean, InnerWorkings and Echo Global Logistics. He received his bachelor’s degree from the University of Michigan before earning his JD from the University of Michigan Law School.

Accelerated Disruption

Accelerated Disruption is business development moving at high technological speed. According to Lefkofsky, each day someone has a disruptive business idea that can transform the market in terms of convenience, price, functionality, service and price. However, most of these people fail to realize that the swift pace of technology allows challenges to come from both established competitors and startups. Lefkofsky argues that only the businesses that understand and control the technology forces will thrive in the future. Click Here for more.

On the other hand, entrepreneurs who cannot control the external forces will be soon displaced. According to Lefkofsky, to succeed in competitive industries, one has to choose the right sector to invest in and understand all the dynamics of the selected venture. Moreover, one should develop capital strategies to support the business during critical stages.

Charitable Causes

Lefkofsky is also involved in various philanthropic activities. In 2006, Lefkofsky and his wife founded Lefkofsky Foundation, which is committed to empowering the living standards of the people. The Foundation improves the quality of human life with a focus on human rights, healthcare, art, and education. So far Lefkofsky has donated to organizations dealing with research in the treatment of Leukemia, lung and thyroid cancer.

About Tempus

Tempus is a health technology company that has made its name globally for creating a platform that helps doctors offer personalized cancer treatment. With this platform, doctors are provided with genomic sequencing services helping them make real-time decisions, which are driven by data. This technology is essential in analyzing molecular and therapeutic data helping a patient to benefit from the treatment of other patients who came before.

Visit http://lefkofskyfoundation.com/about-eric-lefkofsky for more.